基于蛋白组学探讨糖皮质激素性骨质疏松发病机制
摘要点击次数: 1183   全文下载次数: 391   投稿时间:2022-12-26    
作者Author单位AddressE-Mail
张方晴 ZHANG Fang-qing 中国医学科学院药用植物研究所, 北京 100193
中国中医科学院望京医院, 北京 100102
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China
Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing 100102, China
 
李秋月 LI Qiu-yue 中国中医科学院望京医院, 北京 100102 Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing 100102, China  
石钺 SHI Yue 中国医学科学院药用植物研究所, 北京 100193 Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China shiyue1029@126.com 
王镜勋 WANG Jing-xun 中国医学科学院药用植物研究所, 北京 100193 Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China  
吴嘉朔 WU Jia-shuo 中国医学科学院药用植物研究所, 北京 100193 Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China  
阮豪南 RUAN Hao-nan 中国医学科学院药用植物研究所, 北京 100193 Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China  
薛昊天 XUE Hao-tian 中国医学科学院药用植物研究所, 北京 100193
河北大学公共卫生学院, 河北 保定 071000
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China
College of Public Health, Hebei University, Baoding 071000, Hebei, China
 
期刊信息:《中国骨伤》2023年,第36卷,第4期,第336-344页
DOI:10.12200/j.issn.1003-0034.2023.04.008
基金项目:中国中医科学院科技创新工程课题(编号:CI2021A04901);中国医学科学院医学与健康科技创新工程项目(编号:2016-12M-1-102);中国中医科学院优秀青年科技人才(创新类)培养专项(编号:ZZ13-YQ-036);中国中医科学院望京医院苗圃培育项目(编号:WJYY-YJKT-2022 -04)
中文摘要:

目的: 基于Label-free非标全蛋白组学方法探讨糖皮质激素性骨质疏松(glucocorticoid-induced osteoporosis,GIOP)的发病机制。

方法: 将12只SPF级SD雌性大鼠随机分为空白对照组和GIOP组。适应性饲养1周后,GIOP组按2.5 mg/kg体重于左右大腿内侧交替注射地塞米松,空白对照组注射等量的生理盐水,每周2次。造模8周末,取各组大鼠的胫骨进行病理切片,以确定造模成功。每组选取3个样本进行蛋白质组学检测,在质控后通过蛋白质的定性定量分析筛选差异蛋白,并通过生物信息学手段针对差异蛋白进行聚类分析,利用基因本体论(gene ontology,GO)、KEGG (Kyoto encyclopedia of genes and genomes,KEGG)等功能富集分析手段,以阐明糖皮质激素(glucocorticoids,GCs)诱发的GIOP的潜在病理机制。

结果: 与空白对照组比较,GIOP组大鼠骨小梁排列紊乱,分布不均且伴有断裂现象,骨空腔间隙增加,具有显著差异,证明造模成功。蛋白组学检测共鉴定47个差异表达蛋白,其中20个蛋白上调,27个蛋白下调。蛋白核磷蛋白1(nucleophosmin 1,NPM1)、脂肪细胞膜关联蛋白(adipocyte plasma membrane associated protein,APMAP)、抗酒石酸酸性磷酸酶5(tartrate-resistant acid phosphatase,ACP5)、细胞色素c氧化酶6A (cytochromec oxidase subunit 6A1,COX6A1)等蛋白表达具有显著差异。KEGG结果显示,差异表达蛋白富集在代谢相关通路、免疫炎症相关通路及腺苷酸活化蛋白激酶(AMP-activated kinase,AMPK)信号通路上。

结论: NPM1、APMAP、COX6A1、ACP5等蛋白与GIOP的发病机制密切相关,可作为GIOP的潜在生物标志物。AMPK信号通路在GIOP的发生发展中起重要作用,为治疗GIOP的潜在信号通路。
【关键词】糖皮质激素性骨质疏松  发病机制  全蛋白质组学
 
Pathogenesis of glucocorticoid-induced osteoporosis based on label-free mass proteomics
ABSTRACT  

Objective To explore pathogenesis of glucocortocoid-induced osteoporosis(GIOP) based on label-free mass proteomics.

Methods Twevle female Sprague-Dawley(SD) rats were randomly divided into two groups,named as sham group and GIOP group. After one-week adaptive feeding,the rats of GIOP group were administered with dexamethasone via intramuscular injection according to 2.5 mg/kg weighting,while the rats of sham group were administered with the same amount of saline,twice a week. The tibias of each group were collected after 8-week modeling and made pathological sections to confirm the success of modeling. Three samples of each group were picked up to perform label-free mass proteomics. After quality control,differentially expressed proteins were identified according to qualitative and quantitative analyses. Then gene ontology(GO) and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analysis,cluster analysis as well as protein-protein interaction analysis were performed using bioinformatics analysis.

Results Compared with sham group,the structure of bone trabecular in GIOP group showed abnormal arrangement,uneven distribution and obvious fragmentation,which could demonstrate successful modeling. A total of 47 differentially expressed proteins (DEPs) were identified including 20 up-regulated and 27 down-regulated proteins. The expression of protein nucleophosmin 1(NPM1),adipocyte plasma membrane associated protein (APMAP),cytochromec oxidase subunit 6A1 (COX6A1) and tartrate-resistant acid phosphatase (ACP5) showed a significant difference between two groups. KEGG results showed DEPs were enriched on metabolism-related pathways,immune-related pathways and AMP-activated kinase (AMPK) signaling pathway.

Conclusion Protein NPM1,APMAP,COX6A1 and ACP5 showed a close relationship with pathogenesis of GIOP,which could serve as potential biomarkers of GIOP. AMPK signaling pathway played an important role in the occurrence and development of GIOP,which could be regarded as potential signaling pathway to treatment GIOP.
KEY WORDS  Glucocorticoid-induced osteoporosis  Pathogenesis  Proteomics
 
引用本文,请按以下格式著录参考文献:
中文格式:张方晴,李秋月,石钺,王镜勋,吴嘉朔,阮豪南,薛昊天.基于蛋白组学探讨糖皮质激素性骨质疏松发病机制[J].中国骨伤,2023,36(4):336~344
英文格式:ZHANG Fang-qing,LI Qiu-yue,SHI Yue,WANG Jing-xun,WU Jia-shuo,RUAN Hao-nan,XUE Hao-tian.Pathogenesis of glucocorticoid-induced osteoporosis based on label-free mass proteomics[J].zhongguo gu shang / China J Orthop Trauma ,2023,36(4):336~344
阅读全文  下载  查看/发表评论  下载PDF阅读器
关闭




版权所有:《中国骨伤》杂志社京ICP备12048066号-2  版权声明
地址:北京市东直门内南小街甲16号,100700
电话:010-64089487 传真:010-64089792 Email:zggszz@sina.com

京公网安备 11010102004237号